Think Biosolution is an Irish-based wearable technology company that was co-founded by Dr. Shourjya Sanyal and Koushik Kumar Nundy in March 2016. Their first product, the QuasaR, can measure heart rate, heart rate variability, respiratory rate, and blood oxygen saturation more accurately than any other photodiode-based sensor technology available on the market. The company’s vision […]
Month: November 2017
Vibrator Detects Protein Biomarkers of Disease, Already Tried as Concussion Detector
Scientists at Purdue University have developed a novel new way of detecting biomarkers within blood and other bodily fluids, potentially opening the possibility of being able to quickly and easily detect a wide variety of diseases and monitor their progress. The team’s microelectromechanical system (MEMS) relies on vibration to spot a looked-for biomarker within the […]
KardiaBand for The Apple Watch Records ECG, Detects Atrial Fibrillation
Watching the rhythm of your heart is getting quite a bit easier. AliveCor, the originators of the to-go ECG smartphone market, have announced FDA clearance of the KardiaBand single-lead ECG device for the Apple Watch. The device is capable of detecting atrial fibrillation, a common heart rhythm disorder that’s difficult to diagnose, and because it’s always […]
NovaBay reports $2.4 million net loss in third quarter
NovaBay Pharmaceuticals reported a net loss of $2.4 million, or $0.16 per share, for the third quarter of 2017 compared with a net loss of $3.7 million, or $0.34 per share, for the third quarter of 2016.
Net sales for the quarter rose from $3.4 million to $4.1 million, according to a company press release.
Sales and marketing expenses increased from $2.7 million in 2016’s third quarter to $3.3 million in the third quarter of 2017, which was attributed to an increase in the number of sales representatives and increased sampling and marketing programs.
General and administrative costs were
RICOH MEG Magnetoencephalography System Wins FDA Clearance
Ricoh, a large Japanese industrial company, won FDA clearance for its RICOH MEG magnetoencephalography system. The device is able to detect electrical signals within the brain by measuring the magnetic fields produced as electric currents move within the brain. According to the company, the device was developed to provide “deeper measurement (hippocampus and hypothalamus), clearer signal […]
Legal Risks of Delegating Informed Consent to an NP or PA
Some physicians delegate all or part of the informed consent process to their nurse practitioner or physician assistant. But this could create problems for the physician. Medscape Business of Medicine
War on Cancer: A Patient’s Journey, Comes to London
On November 21st The Economist newspaper declared War on Cancer for the third time in London, drawing world experts in oncology policy, clinical practice, and innovation together in the unique and fitting venue of the Honorable Artillery Company. With over 200 known types of cancer and each patient’s unique physiology leading to huge variations in treatment […]
Amputees Move Robotic Arms by Power of Thought
Scientists at the University of Chicago have shown that it is possible to implant brain-computer interfaces and let amputees control robotic arms, even years after their amputations. Similar research has previously focused on paralyzed people and whether they can benefit from technology that lets them move external devices by simply willing and thinking of wanted […]
Reproxalap non-inferior to Pred Forte for noninfectious anterior uveitis in phase 2 trial
A phase 2 clinical trial showed topical ocular reproxalap to be non-inferior to Pred Forte in patients with noninfectious anterior uveitis, Aldeyra Therapeutics announced in a press release.The randomized, multicenter, investigator-masked, comparator-c…
Global Ocular Drug Delivery Technology Market to 2025 by Technology, Indication & Geography – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Global Ocular Drug Delivery Technology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025” report has been added to Research an…
Glaukos posts $1.3 million in quarterly net income
Glaukos posted a net income of $1.3 million, or $0.04 per diluted share, for the third quarter of 2017 compared with a net income of $1.2 million, or $0.03 per diluted share, for the third quarter of 2016, according to a press release.
Net sales increased to $40.4 million compared with $29.6 million in the same quarter of 2016, which Glaukos attributed to higher selling prices and an expansion of its direct sales operations in new international markets.
Operating expenses rose from $24.7 million in 2016’s third quarter to $33.9 million, while income from operations declined from $1
Dr. John J. Kownacki, Ophthalmologist, Joins Trilogy Eye Medical Group (Acuity Eye Group™)
PASADENA, Calif. & SAN DIEGO–(BUSINESS WIRE)–Dr. John J. Kownacki, Ophthalmologist, joins Trilogy Eye Medical Group (Acuity Eye Group™).
Aenitis Technologies Receives €4 Million in Funding from the European H2020 / SME Instrument Programme, for Its ABC-S’ Project (Acoustic Blood Cell Sorter)
PARIS–(BUSINESS WIRE)–Aenitis Technologies, which develops new medical equipment based on acoustic manipulation of biological particles, today announced that it has received €4 million in funding, following its application to the highly-selective SME Instrument Phase 2 European programme, in the “Healthcare Biotechnology” category. SME Instrument Phase 2 is part of Horizon 2020, a programme managed by the European Commission and dedicated to innovation and research. It is part of the Industri
ACP proposes ways to improve testing new payment models
In a letter to CMS, the ACP voiced its support of the Center for Medicare and Medicaid Innovation’s move towards value-based payment models, but also expressed several significant reservations on the testing approaches for new payment models, as well as their impact on disadvantaged patients.
“There are a number of components of these principles that ACP supports; however, we also have significant concerns about some of the language used in terms of what it will mean for the implementation of the key concepts,” Jacqueline Fincher, MD, MACP, chair of ACP’s Medical
Glaukos Announces Issuance of New U.S. Patent
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 9,827,143 to the company. Entitled “Shunt Device and Method for Treating Ocular Disorders”, the newly issued patent covers ocular devices and methods of
VIDEO: IRIS Registry study shows diabetic macular edema undertreated in US
NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Jeffrey R. Willis, MD, PhD, assistant medical director at Genentech, discusses a large retrospective study using the IRIS Registry to observe patients identified with diabetic macular edema and the treatments most used. The study found most patients were not treated regularly enough over a 1-year interval.
Carefully Controlled Light Pulses Can Trigger Neurons to Fire
Researchers at the University of Illinois have developed a technique of using a flurry of very short light pulses of different wavelengths to control how mouse neurons fire. Eventually, the technique might be useful for influencing cells in the body that respond to light, such as those in the retina, to treat light-sensitive circadian or […]
Duke University Heart Patch Shows Promise in Repairing Cardiac Tissue Damage
Researchers at Duke University have developed an artificially-engineered patch consisting of fully functional human heart muscle tissue that can be used to repair damaged areas of the heart. While it’s not the first cardiac tissue to be artificially engineered, it’s significant in that it’s the first that is large enough to be clinically useful to […]
Global Bacterial Conjunctivitis Market 2017-2025 – $436.7 Million Application Analysis, Growth Trends & Key Players – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Global Bacterial Conjunctivitis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025” report has been added to Research and Marke…
Flosstime Automated Floss Dispenser: A Medgadget Review
In the field of dentistry, gadgets for your pearly whites have tracked along fairly well with advancements in technology. You can now buy Bluetooth-enabled toothbrushes and let a robot drill holes in your mouth to place a dental implant. But one too often overlooked practice that hasn’t yet been modernized is flossing. No matter how […]